Moreover, when assessing the risk of HCC recurrence, the preS2-mutant LHBS is combined with other high-risk markers such as AFP and des-gamma-carboxy prothrombin to improve the precision of prediction of prognosticating HCC recurrence risk post-hepatectomy [194, 195]. Here, DES is linked to hepatocellular carcinoma.